Skip to content

Clinical trials

Observational Thromboembolism trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Observational Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20092
20101
20123
20132
20152
20161
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
Bayer2
Boehringer Ingelheim2
Biotronik SE & Co. KG1
Boston Scientific Corporation1
Center for Epidemiology and Health Research, Germany1
GlaxoSmithKline1
Inari Medical1
Johannes Gutenberg University Mainz1
Mylan Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism15
Atrial Fibrillation4
Stroke3
Thrombosis3
Venous Thromboembolism3
Cardiovascular Diseases2
Pulmonary Embolism2
Atherosclerosis1
Breast Neoplasms1
COVID-191

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.